Avalo Therapeutics Inc【AVTX】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -383,412 -16.0%
4Q24 -370,263 +10.5%
3Q24 -334,924 +2.4%
2Q24 -357,961 +11.3%
1Q24 -456,424 +45.5%
4Q23 -335,134 +10.3%
3Q23 -326,966 +11.2%
2Q23 -321,738 +8.3%
1Q23 -313,800 +10.4%
4Q22 -303,800 +15.9%
3Q22 -294,000 +21.0%
2Q22 -297,200 +31.7%
1Q22 -284,200 +36.3%
4Q21 -262,200 +47.5%
3Q21 -243,000 +49.9%
2Q21 -225,600 +51.7%
1Q21 -208,500 +54.0%
4Q20 -177,800 +55.6%
3Q20 -162,100 +39.9%
2Q20 -148,690 +32.9%
1Q20 -135,408 +28.1%
4Q19 -114,291 +16.4%
3Q19 -115,900 +25.1%
2Q19 -111,900 +64.4%
1Q19 -105,700 +70.5%
4Q18 -98,200 +68.8%
3Q18 -92,660 +68.2%
2Q18 -68,056 -7.8%
1Q18 -62,000 -13.9%
4Q17 -58,166 -16.9%
3Q17 -55,100 -19.4%
2Q17 -73,795 +18.6%
1Q17 -71,996 +22.6%
4Q16 -70,036 +30.8%
3Q16 -68,397 +37.0%
2Q16 -62,228 -
1Q16 -58,704 -
4Q15 -53,564 -
3Q15 -49,915 -